Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (841-850 of 968) with videos related to

Pageof 97
Sort By:
Mayo Clinic Proceedings|February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified TypingEli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working GroupMeletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
American Journal of Hematology|March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosisNidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances|February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosisNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2018
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative DisordersLarissa Higgins, Samih H Nasr, Samar M Said, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Pageof 97

Showing results (841-850 of 968) with videos related to

Sort By:
Pageof 97
Mayo Clinic Proceedings|February 17, 2019
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified TypingEli Muchtar, Morie A Gertz, Robert A Kyle, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
Leukemia|October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United StatesMoritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working GroupMeletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
American Journal of Hematology|March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosisNidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood Advances|February 17, 2021
Prognostic restaging after treatment initiation in patients with AL amyloidosisNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2018
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative DisordersLarissa Higgins, Samih H Nasr, Samar M Said, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Pageof 97